Agusti Alentorn Selected Research

Agusti Alentorn Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 05/2014
8	Glioma (Gliomas) 01/2023 - 09/2014
7	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 05/2013
4	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023 - 05/2020
4	Cerebellar Ataxia (Dysmetria) 01/2023 - 05/2020
4	Lymphoma (Lymphomas) 01/2022 - 01/2017
3	Oligodendroglioma 12/2019 - 01/2016
2	Autoimmune Diseases of the Nervous System 11/2023 - 02/2023
2	Brain Neoplasms (Brain Tumor) 05/2023 - 01/2023
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2021 - 05/2020
2	Carcinogenesis 01/2019 - 12/2018
2	Astrocytoma (Pilocytic Astrocytoma) 01/2016 - 01/2015
1	Sleepiness 11/2023
1	Sleep Wake Disorders 11/2023
1	Disorders of Excessive Somnolence (Hypersomnia) 11/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2023
1	Encephalomyelitis (Myeloencephalitis) 01/2023
1	Autoimmune limbic encephalitis 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Encephalitis (Encephalitis, Rasmussen) 01/2023
1	Ataxia (Dyssynergia) 01/2022
1	Infections 09/2021
1	COVID-19 09/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2020
1	Turcot syndrome 01/2020
1	Necrosis 12/2019
1	Central Nervous System Neoplasms 12/2019
1	Aseptic Meningitis 01/2019
1	Diffuse Intrinsic Pontine Glioma 10/2018
1	Hemangiopericytoma 09/2018
1	Solitary Fibrous Tumors 09/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Paraneoplastic Cerebellar Degeneration 01/2018
1	Hypoxia (Hypoxemia) 01/2016
1	Lung Neoplasms (Lung Cancer) 11/2015
1	Melanoma (Melanoma, Malignant) 11/2015
1	Circulating Neoplastic Cells 01/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2015
5	AntibodiesIBA 01/2023 - 05/2020
4	Biomarkers (Surrogate Marker)IBA 12/2017 - 05/2014
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 11/2023 - 01/2021
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 12/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 06/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2018 - 05/2013
2	Vincristine (Oncovin)FDA LinkGeneric 06/2017 - 01/2015
2	Procarbazine (Matulane)FDA Link 06/2017 - 01/2015
2	Lomustine (CCNU)FDA Link 06/2017 - 01/2015
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 11/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2023
1	mesoglycanIBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	IronIBA 09/2021
1	ferrocifenIBA 09/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	HLA-DRB1*07 antigenIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	hemoglobin ASIBA 01/2019
1	ChromatinIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	MicroRNAs (MicroRNA)IBA 12/2018
1	dipinacoline glutamateIBA 10/2018
1	pazopanib FDA Link 09/2018
1	anti-Yo autoantibodiesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	CytokinesIBA 12/2017
1	P-2 (P 2)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	VemurafenibIBA 01/2015
1	Everolimus FDA Link 01/2015
1	Nucleic AcidsIBA 01/2015
1	Complement System Proteins (Complement)IBA 09/2014
1	Formaldehyde (Formol)FDA Link 09/2014
1	ParaffinIBA 09/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2013

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
4	Therapeutics 01/2023 - 01/2015
3	Radiotherapy 05/2023 - 11/2015
2	Precision Medicine 12/2018 - 11/2015
1	Artificial Respiration (Mechanical Ventilation) 09/2021
1	Aftercare (After-Treatment) 01/2020
1	Biological Therapy 12/2017
1	Molecular Targeted Therapy 11/2015